Novo Nordisk, maker of Wegovy, and Eli Lilly, maker of Zepbound, both launched direct-to-consumer telehealth platforms to streamline access
While semaglutide and tirzepatide both reduce appetite through similar pathways, alternating between them is not a standard clinical strategy and carries distinct safety and efficacy considerations that PlexusDx providers carefully evaluate for each patient
Delivers nutrients directly to the bloodstream, bypassing the digestive tract for efficient uptake
MHC II, Major Histocompatibility Complex Class II
While there are a few annoyances, they haven't been dealbreakers
The critical point: adding more peptides to a protocol does not change how you calculate retatrutide doses